Latest Mammaprint Stories
LONDON, May 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
DUBLIN, April 9, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/k3xnm6/molecular) has announced the addition of the "Molecular
In an innovative clinical trial led by UC San Francisco, the experimental drug neratinib along with standard chemotherapy was found to be a beneficial treatment for some women with newly diagnosed, high-risk breast cancer.
DUBLIN, April 3, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/fz82h5/biomarkers ) has announced the addition of the "Biomarkers:
The rapid growth of the Cancer Profiling Market is attributed to its promising application in personalized cancer therapy; and its extension in early diagnosis, disease prognosis, and research
A new test has the potential to help physicians identify patients with the most lethal forms of triple-negative breast cancer, a disease which requires aggressive and innovative treatment.
Reportbuyer.com just published a new market research report:
Cancer/Tumor Profiling Market report categorizes the global cancer/tumor profiling market into geography, applications, technologies, and segment types.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.